Falls are among the most serious problems faced by older persons and
are associated with considerable morbidity and mortality. Falls are multifactorial in origin. Hence, assessment of falls and fall risk is a
complex task. An important risk factor for falls is the use of certain drugs, i.e., fall risk-increasing drugs (FRIDs). The exact contribution of FRIDs use to fall risk is not known. To date, information about the effects and effectiveness of FRIDs withdrawal on falls in older persons is scarce.
There is evidence that withdrawal of psychotropics reduces rate of falls and that a prescribing modifi cation program for primary care physicians can reduce risk of falling. Withdrawal of all FRIDs, including cardiovascular and psychotropic drugs, appears to be an effective intervention for lowering fall incidence and can lead to improvement of mobility tests and cardiovascular end points. Withdrawal of psychotropics, especially benzodiazepines (BZD), was an important factor in lowering risk of falls requiring medical treatment during the fi rst year after a 12-month multifactorial intervention. BZD withdrawal has also been shown to result in a signifi -
cant improvement in the stability of the body, a recovery of cognitive functions, and improvement of handgrip strength and balance.
Pharmacological interventions, including withdrawal of FRIDs, pharmacistconducted clinical medication review, and computerized drug alerts, are effective in reducing fall risk and should be incorporated in the care of older persons.
Original languageEnglish
Title of host publicationMedication-Related Falls in Older People
Subtitle of host publicationCausative Factors and Management Strategies
EditorsAllen R. Huang, Louise Mallet
PublisherSpringer
Pages199-211
Number of pages13
EditionPart IV
ISBN (Electronic)978-3-319-32304-6
ISBN (Print)978-3-319-32302-2
DOIs
Publication statusPublished - 2016

    Research areas

  • Benzodiazepines or related drug, Control group, Drug–drug interaction, Fall risk-increasing drugs, Intervention group, Interquartile range, Nonsteroidal anti-infl ammatory drugs, Randomized controlled trial, Standard deviation, Timed up and Go, United States

ID: 7034016